These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 27365023)

  • 1. [Update on kinase inhibitors].
    Alten R
    Z Rheumatol; 2016 Aug; 75(6):611-5. PubMed ID: 27365023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glucocorticoids].
    Gromnica-Ihle E
    Z Rheumatol; 2016 Aug; 75(6):591-4. PubMed ID: 27412667
    [No Abstract]   [Full Text] [Related]  

  • 3. [Methotrexate].
    Rau R
    Z Rheumatol; 2016 Aug; 75(6):599-603. PubMed ID: 27365027
    [No Abstract]   [Full Text] [Related]  

  • 4. [Biologics].
    Kalden JR
    Z Rheumatol; 2016 Aug; 75(6):604-10. PubMed ID: 27365024
    [No Abstract]   [Full Text] [Related]  

  • 5. [Intracellular targets : current data on effectiveness and safety profile].
    Alten R
    Z Rheumatol; 2013 Nov; 72(9):867-72. PubMed ID: 24193189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent progress in the medical treatment of rheumatoid arthritis].
    Takeuchi T
    Nihon Yakurigaku Zasshi; 2007 Mar; 129(3):182-5. PubMed ID: 17379969
    [No Abstract]   [Full Text] [Related]  

  • 7. [Coxibs].
    Bolten WW; Krüger K
    Z Rheumatol; 2016 Aug; 75(6):595-8. PubMed ID: 27418054
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rheumatoid arthritis].
    Aletaha D; Kerschbaumer A
    Z Rheumatol; 2017 Feb; 76(1):8-14. PubMed ID: 28058499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose optimization of infliximab in patients with rheumatoid arthritis.
    Alten R; van den Bosch F
    Int J Rheum Dis; 2014 Jan; 17(1):5-18. PubMed ID: 24472261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infliximab-associated pneumonitis in rheumatoid arthritis.
    Hennum J; Nace J; Shammash E; Gertner E
    J Rheumatol; 2006 Sep; 33(9):1917-8. PubMed ID: 16960963
    [No Abstract]   [Full Text] [Related]  

  • 11. [Rheumatoid arthritis plus osteoporosis. How much corticoid will this patient still tolerate?].
    Fassbender WJ
    MMW Fortschr Med; 2012 Feb; 154(3):34. PubMed ID: 22458166
    [No Abstract]   [Full Text] [Related]  

  • 12. [O'Dell reloaded: Do we use TNF inhibitors too early?].
    Krüger K
    Z Rheumatol; 2014 Mar; 73(2):111-2. PubMed ID: 24129424
    [No Abstract]   [Full Text] [Related]  

  • 13. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactions to infliximab in patients with rheumatoid arthritis.
    Sakellariou GT; Chatzigiannis I
    J Rheumatol; 2005 Jul; 32(7):1411-2. PubMed ID: 15996088
    [No Abstract]   [Full Text] [Related]  

  • 15. Small molecular therapies for rheumatoid arthritis: where do we stand?
    Cohen S
    Expert Opin Investig Drugs; 2012 Jan; 21(1):23-31. PubMed ID: 22070089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
    Baslund B; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for rheumatoid arthritis. Practical guidance for optimizing treatment.
    Furfaro N
    Adv Nurse Pract; 2008 Jan; 16(1):61-4. PubMed ID: 20014746
    [No Abstract]   [Full Text] [Related]  

  • 18. Basal anti-cyclic citrullinated peptide (anti-CCP) antibody levels and a decrease in anti-CCP titres are associated with clinical response to adalimumab in rheumatoid arthritis.
    Cuchacovich M; Catalan D; Wainstein E; Gatica H; Soto L; Aravena O; Pesce B; Sabugo F; Aguillón JC
    Clin Exp Rheumatol; 2008; 26(6):1067-73. PubMed ID: 19210871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Golimumab (simponi) for inflammatory arthritis.
    Med Lett Drugs Ther; 2009 Jul; 51(1316):55-6. PubMed ID: 19590489
    [No Abstract]   [Full Text] [Related]  

  • 20. [TNF-alpha inhibitors and demyelinating disease].
    Böttiger Y
    Lakartidningen; 2007 Nov 7-13; 104(45):3384. PubMed ID: 18062640
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.